PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.\', \'Centre for Health Economics Research and Modelling of Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium.\', \'Global Health Institute (GHI), Family Medicine and Population Health (FAMPOP), University of Antwerp, Wilrijk, Belgium.\', \'Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.\', \'Data Science Institute (DSI), Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), UHasselt, Hasselt, Belgium.\', \'Algemeen Medisch Laboratorium (AML), Sonic Healthcare, Antwerp, Belgium.\', \'Laboratoire Luc OLIVIER, Fernelmont, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2807/1560-7917.ES.2022.27.9.2100419
?:doi
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 35241216
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all